TickerFacts.

NeoGenomics Inc (NEO): Total Assets

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2015-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$1.36B
As of 2025-12-31
$1.35B
As of 2026-06-30
-7.9%
3-year compound annual growth
+6.6%
5-year compound annual growth
+14.5%
10-year compound annual growth
$1.87B2010-12-31: $13.65M2011-12-31: $19.95M2012-12-31: $30.07M2013-12-31: $39.92M2014-12-31: $81.11M2015-12-31: $351.29M2016-12-31: $337.12M2017-12-31: $344.45M2018-12-31: $505.01M2019-12-31: $709.51M2020-12-31: $988.33M2021-12-31: $1.87B2022-12-31: $1.74B2023-12-31: $1.68B2024-12-31: $1.64B2025-12-31: $1.36B$1.36B
2010-12-31 Total Assets (USD) 2025-12-31
Period endedTotal AssetsChange YoYSource filing
2025-12-31$1.36B-17.0%2026-02-17, Balance as of period end
2024-12-31$1.64B-2.6%2026-02-17, Balance as of period end
2023-12-31$1.68B-3.4%2025-02-18, Balance as of period end
2022-12-31$1.74B-6.9%2024-02-20, Balance as of period end
2021-12-31$1.87B+89.2%2023-02-24, Balance as of period end
2020-12-31$988.33M+39.3%2022-02-25, Balance as of period end
2019-12-31$709.51M+40.5%2021-02-25, Balance as of period end
2018-12-31$505.01M+46.6%2020-02-28, Balance as of period end
2017-12-31$344.45M+2.2%2019-02-26, Balance as of period end
2016-12-31$337.12M-4.0%2018-03-13, Balance as of period end
2015-12-31$351.29Mn/c2017-03-14, Balance as of period end
2014-12-31$81.11M+103.2%2016-04-18, Balance as of period end
2013-12-31$39.92M+32.7%2015-03-03, Balance as of period end
2012-12-31$30.07M+50.7%2014-02-24, Balance as of period end
2011-12-31$19.95M+46.1%2013-02-21, Balance as of period end
2010-12-31$13.65Mn/a2012-03-12, Balance as of period end

Total Assets at similar companies

Companies with the same SEC industry code (Services-Testing Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal AssetsChange YoY
NeoGenomics Inc (NEO)2025-12-31$1.36B-17.0%
UL Solutions Inc. (ULS)2025-12-31$2.92B+4.3%
20/20 Biolabs, Inc. (AIDX)2025-12-31$4.14M+15.4%
Hypha Labs, Inc. (FUNI)2025-09-30$409.2K-17.1%

Compare NEO, ULS, AIDX, FUNI side by side · Screen every company in Services-Testing Laboratories ↗